Latest DEF 14A proxy statements

Nukkleus Inc. calls a Special Meeting to approve the acquisition of Star Capital 26, Inc., along with significant equity issuances for warrants and an equity line of credit, all requiring Nasdaq compliance.

Pelthos Therapeutics Inc. will hold its 2025 Annual Meeting to elect directors, ratify auditors, and approve a critical waiver for its $18 million convertible note financing, which could lead to significant shareholder dilution.

Jet.AI Inc. calls for its 2025 Annual Meeting to vote on critical proposals including a significant increase in authorized shares, a potential reverse stock split, and equity compensation plan amendments.

Bitcoin Depot Inc. announces its 2025 Annual Meeting of Stockholders to be held virtually on December 12, 2025, where key proposals include director elections and auditor ratification, alongside significant executive leadership changes for 2026.

Commercial Metals Company reports strong fiscal year 2025 operational and strategic progress, including significant acquisitions and a successful operational excellence program, ahead of its January 2026 Annual Meeting.

Cantor Equity Partners, Inc. is reminding shareholders to cast their votes for the upcoming Extraordinary General Meeting scheduled for December 3, 2025.

WideOpenWest, Inc. issued supplemental disclosures to its merger proxy statement to address a shareholder lawsuit alleging deficiencies and to avoid potential delays to its acquisition by DigitalBridge and Crestview affiliates.

TrueCar, Inc. stockholders are invited to a special meeting on December 22, 2025, to vote on a proposed all-cash merger with Fair Holdings, Inc. at $2.55 per share, backed by founder Scott Painter and Alpha Auto 2, LLC.

Enviri Corporation announced the sale of its Clean Earth business to Veolia Environnement S.A. for $3 billion, with plans to distribute significant cash to shareholders and spin off its remaining Harsco Environmental and Rail businesses as 'New Enviri'.

Enviri Corporation announces the $3 billion sale of its Clean Earth business to Veolia Environnement S.A. and plans to spin off Harsco Environmental and Harsco Rail as 'New Enviri'.

UniFirst Corporation issues definitive proxy statement for its December 15, 2025 Annual Meeting, facing a contested director election from activist investor Engine Capital LP.

Neuphoria Therapeutics Inc. urges stockholders to vote for its director nominees to ensure stability during a critical strategic review process, following a failed Phase 3 clinical trial.

Coinbase Global, Inc. is reincorporating from Delaware to Texas, citing Texas's pro-business and pro-crypto legal environment and potential cost savings.

Institutional Shareholder Services (ISS) has recommended Tiptree stockholders vote FOR the merger of its subsidiary Fortegra with DB Insurance Co., Ltd. in an all-cash deal.

Akero Therapeutics filed a supplement to its definitive proxy statement for the upcoming special meeting, providing additional disclosures regarding its proposed merger with Novo Nordisk and addressing two stockholder lawsuits.

dMY Squared Technology Group, Inc. is seeking shareholder approval to extend its deadline to complete a business combination with Horizon Quantum Computing Pte. Ltd. until June 29, 2026, following its delisting from NYSE American.

The OLB Group, Inc. announces its 2025 Annual Meeting of Stockholders to vote on director elections, auditor ratification, and executive compensation.

Churchill Capital Corp IX announced its annual general meeting for December 19, 2025, primarily to ratify the selection of WithumSmith+Brown, PC as its independent auditor for the fiscal year ending December 31, 2025.

Enviri Corporation announced a definitive agreement to sell its Clean Earth business to Veolia for $3 billion and spin off Harsco Environmental and Rail into a new public company, New Enviri.

Nocera, Inc. will hold its 2025 Annual Meeting to vote on key proposals including a reverse stock split, an increase in authorized shares, and the potential issuance of common stock from convertible securities.

Enviri Corporation announces the sale of its Clean Earth business to Veolia Environnement S.A. for $3 billion, significantly reducing debt and creating a new, financially healthier 'New Enviri' focused on Harsco Environmental and Rail.

Movano Inc. calls a special meeting to approve a $1 billion equity facility, a five-fold increase in authorized shares, and expanded stock options for employees and directors amid financial constraints.

VSee Health, Inc. will hold its Annual Meeting on December 15, 2025, to vote on director elections, auditor ratification, and a new equity incentive plan, amidst disclosures of financial difficulties and deferred executive salaries.

Minerva Neurosciences will hold its 2025 Annual Meeting to vote on increasing authorized shares, approving Series A Preferred Stock conversion, and amending its equity incentive plan, crucial for future funding and talent retention.

Allurion Technologies, Inc. is seeking stockholder approval for a reverse stock split, an amended equity incentive plan, option repricing, and the issuance of shares for debt conversion to address NYSE listing requirements and enhance long-term value.

Digital Ally, Inc. is seeking stockholder approval for significant dilutive equity issuances and an increase in its stock option plan to fund operations amidst ongoing net losses.

Tamboran Resources Corporation calls a Special Meeting to ratify a public offering and approve a private placement, totaling approximately $88 million in new equity to fund its development plan.

IBEX Limited has established a formal Nominating Committee to address shareholder concerns and enhance its corporate governance structure.

Neuphoria Therapeutics Inc. issues its definitive proxy statement for its December 12, 2025 Annual Meeting, facing a proxy contest from activist investor LYNX1 Master Fund LP and addressing key governance proposals following a significant clinical trial failure.

CompoSecure, Inc. seeks stockholder approval for a strategic combination with Husky Technologies Limited, valued at approximately $3.953 billion in cash and 55.3 million shares of CompoSecure common stock.